Zydus Lifesciences Ltd.
Research Zydus Lifesciences Ltd. (ZYDUSLIFE.NS) on Bullrun: market cap INR 1.12T, P/E 25.0, dividend yield 0.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZYDUSLIFE.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 1.12T
- P/E25.0
- Dividend yield0.1%
- Financial periodQ2 2026
- RevenueINR 78.02B
- Net incomeINR 9.40B
- Gross margin71.3%
Valuation Snapshot
latest market cap is INR 1.12T; P/E is 25.0; dividend yield is 0.1%.
Peer valuation comparison
Latest P/E is 25.03x versus a Healthcare sector median of 21.74x (15.1% above).
Latest dividend yield is 0.09% versus a Healthcare sector median of 2.4% (96.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 1.12T | 25.0 | 0.1% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1 INR, yield 0.1%.
About Zydus Lifesciences Ltd.
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zydus Lifesciences Ltd.'s market cap?
Zydus Lifesciences Ltd.'s market capitalization is INR 1.12T.
What is Zydus Lifesciences Ltd.'s P/E ratio?
Zydus Lifesciences Ltd.'s price-to-earnings (P/E) ratio is 25.0.
Does Zydus Lifesciences Ltd. pay a dividend?
Zydus Lifesciences Ltd. has a dividend yield of 0.1%.
What does Zydus Lifesciences Ltd. do?
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products.